Frequency Therapeutics (FREQ) executive Lucchino sold 5,266 shares for $2,926 at an average $0.56 under a 10b5-1 plan
Insider transactions reported
David L. Lucchino (executive at Frequency Therapeutics Inc., FREQ) reported that they sold 5,266 shares for $2,926 at an average $0.56 between Aug 2, 2023 and Aug 3, 2023. After these transactions the filing shows 667,342 shares held directly.
- Reporting person
- Lucchino David L.
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Aug 2, 2023 | Open-market sale (S) | Common Stock1, 2 | -2,587 | $0.52 | $1,345 | 670,021 direct |
| Aug 3, 2023 | Open-market sale (S) | Common Stock1, 3 | -2,679 | $0.59 | $1,581 | 667,342 direct |
Holdings before and after
- Common Stock: 672,608 to 667,342 direct
Footnotes from the filing
- 1. Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
- 2. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.480 to $0.543. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
FAQ
What did Lucchino report in this FREQ Form 4?
David L. Lucchino (executive at Frequency Therapeutics Inc., FREQ) reported that they sold 5,266 shares for $2,926 at an average $0.56 between Aug 2, 2023 and Aug 3, 2023. After these transactions the filing shows 667,342 shares held directly.
How many FREQ shares does Lucchino hold after this filing?
The filing shows 667,342 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this FREQ insider sale made under a 10b5-1 plan?
The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for FREQ
Earlier insider filings at FREQ
- Aug 4, 2023SEC Form 4: Mitrano Richard J. sold $243 worth of shares (463 units at $0.53), decreasing direct ownership by 0.89% to 51,272 units
- Aug 2, 2023SEC Form 4: Lucchino David L. sold $2,710 worth of shares (5,475 units at $0.49), decreasing direct ownership by 0.81% to 672,608 units
- Aug 2, 2023SEC Form 4: Mitrano Richard J. sold $225 worth of shares (460 units at $0.49), decreasing direct ownership by 0.88% to 51,735 units
- Jul 31, 2023SEC Form 4: Mitrano Richard J. sold $225 worth of shares (450 units at $0.50), decreasing direct ownership by 0.85% to 52,195 units
- Jul 31, 2023SEC Form 4: Lucchino David L. sold $2,668 worth of shares (5,438 units at $0.49), decreasing direct ownership by 0.80% to 678,083 units
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2019
Follow FREQ and get a push notification the moment its next story breaks.